Relay Therapeutics, Inc. — Director's Dealing 2023

Jul 31, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2023-07-28

Reporting Person: Adams Brian (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-28	Common Stock	S	1628	$11.80	Disposed	131887	Direct

Footnotes

F1: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units ("RSUs") on July 27, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2: Includes 110,812 shares underlying RSUs.